Geode Capital Management Portfolio holdings
Geode Capital Management, founded in 2001 and based in Boston, Massachusetts, is a prominent institutional asset management firm known for its expertise in low-cost, systematic index investing. Originally established to manage internal index funds for Fidelity Investments, Geode became an independent entity while retaining a close relationship with Fidelity, focusing on passive investment strategies that track major market indices. The firm oversees hundreds of billions in assets, offering a range of mutual funds and separately managed accounts primarily for institutional clients, such as pension funds and endowments, with an emphasis on minimizing costs and maximizing efficiency. Geode’s disciplined, quantitative approach and avoidance of active management have made it a key player in the rise of index-based investing.
Top Buys
| 1 |
Microsoft
MSFT
|
+$1.14B |
| 2 |
Uber
UBER
|
+$1.02B |
| 3 |
Apple
AAPL
|
+$906M |
| 4 |
Broadcom
AVGO
|
+$749M |
| 5 |
NVIDIA
NVDA
|
+$732M |
Top Sells
| 1 |
ATVI
Activision Blizzard Inc.
ATVI
|
+$1.52B |
| 2 |
Danaher
DHR
|
+$586M |
| 3 |
VMW
VMware, Inc
VMW
|
+$474M |
| 4 |
SGEN
Seagen Inc. Common Stock
SGEN
|
+$450M |
| 5 |
HZNP
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
|
+$388M |
Sector Composition
| 1 | Technology | 28.87% |
| 2 | Financials | 12.76% |
| 3 | Healthcare | 12.47% |
| 4 | Consumer Discretionary | 11% |
| 5 | Industrials | 9.08% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
INN
2001
Summit Hotel Properties
INN
$623M
| $17.3M | ﹤0.01% |
2,571,695
+124,352
| +5% | +$836K |
|
|
BELFB
2002
Bel Fuse Class B
BELFB
$1.79B
| $17.3M | ﹤0.01% |
258,770
+7,214
| +3% | +$482K |
|
2003
Bank of N.T. Butterfield & Son
NTB
$1.89B
| $17.3M | ﹤0.01% |
539,780
+11,403
| +2% | +$365K |
|
2004
Waste Connections
WCN
$45.3B
| $17.3M | ﹤0.01% |
112,260
+7,670
| +7% | +$1.18M |
|
|
KREF
2005
KKR Real Estate Finance Trust
KREF
$630M
| $17.2M | ﹤0.01% |
1,299,527
+58,395
| +5% | +$773K |
|
2006
Tompkins Financial
TMP
$1B
| $17.2M | ﹤0.01% |
284,996
+10,875
| +4% | +$655K |
|
2007
Methode Electronics
MEI
$287M
| $17.1M | ﹤0.01% |
752,645
+23,677
| +3% | +$538K |
|
2008
Cabaletta Bio
CABA
$168M
| $17.1M | ﹤0.01% |
753,176
+61,304
| +9% | +$1.39M |
|
2009
Levi Strauss
LEVI
$8.67B
| $17.1M | ﹤0.01% |
1,032,726
+47,827
| +5% | +$791K |
|
2010
Cross Country Healthcare
CCRN
$411M
| $17.1M | ﹤0.01% |
754,003
+29,752
| +4% | +$674K |
|
2011
Bank First Corp
BFC
$1.26B
| $17M | ﹤0.01% |
196,418
+10,045
| +5% | +$871K |
|
2012
AdvanSix
ASIX
$576M
| $17M | ﹤0.01% |
566,475
+17,763
| +3% | +$532K |
|
2013
Arcturus Therapeutics
ARCT
$470M
| $17M | ﹤0.01% |
538,265
+26,097
| +5% | +$823K |
|
2014
ImmunityBio
IBRX
$2.46B
| $17M | ﹤0.01% |
3,379,464
+573,281
| +20% | +$2.88M |
|
|
RVNC
2015
DELISTED
Revance Therapeutics, Inc.
RVNC
| $16.9M | ﹤0.01% |
1,924,421
+144,144
| +8% | +$1.27M |
|
2016
Grid Dynamics Holdings
GDYN
$642M
| $16.9M | ﹤0.01% |
1,268,839
+59,039
| +5% | +$787K |
|
|
INVX
2017
Innovex International, Inc.
INVX
$1.14B
| $16.9M | ﹤0.01% |
726,208
+31,913
| +5% | +$743K |
|
2018
Compañía de Minas Buenaventura
BVN
$5.1B
| $16.8M | ﹤0.01% |
1,112,572
+10,587
| +1% | +$160K |
|
2019
Sturm, Ruger & Co
RGR
$600M
| $16.8M | ﹤0.01% |
369,955
-11,515
| -3% | -$523K |
|
|
CHCT
2020
Community Healthcare Trust
CHCT
$445M
| $16.8M | ﹤0.01% |
630,230
+49,693
| +9% | +$1.32M |
|
|
GMRE
2021
Global Medical REIT
GMRE
$512M
| $16.7M | ﹤0.01% |
1,507,395
+66,600
| +5% | +$739K |
|
2022
Standard Motor Products
SMP
$889M
| $16.7M | ﹤0.01% |
419,743
+12,146
| +3% | +$484K |
|
2023
Regenxbio
RGNX
$465M
| $16.7M | ﹤0.01% |
929,672
+46,526
| +5% | +$835K |
|
2024
B&G Foods
BGS
$360M
| $16.7M | ﹤0.01% |
1,589,104
+115,757
| +8% | +$1.22M |
|
2025
RAPT Therapeutics
RAPT
$268M
| $16.6M | ﹤0.01% |
83,662
+5,051
| +6% | +$1M |
|